Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury

BACKGROUND: Traumatic brain injury (TBI) is a major cause of death and disability. TBI results in a prolonged secondary central neuro-inflammatory response. Previously, we have demonstrated that multiple doses (2 and 24 h after TBI) of multipotent adult progenitor cells (MAPC) delivered intravenousl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedi, Supinder S., Aertker, Benjamin M., Liao, George P., Caplan, Henry W., Bhattarai, Deepa, Mandy, Fanni, Mandy, Franciska, Fernandez, Luis G., Zelnick, Pamela, Mitchell, Matthew B., Schiffer, Walter, Johnson, Margaret, Denson, Emma, Prabhakara, Karthik, Xue, Hasen, Smith, Philippa, Uray, Karen, Olson, Scott D., Mays, Robert W., Cox, Charles S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856201/
https://www.ncbi.nlm.nih.gov/pubmed/29548333
http://dx.doi.org/10.1186/s12974-018-1122-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856201/
https://www.ncbi.nlm.nih.gov/pubmed/29548333
http://dx.doi.org/10.1186/s12974-018-1122-8

Ejemplares similares